Tharimmune (THAR)
NASDAQ:THAR
US Market
Holding THAR?
Track your performance easily

Tharimmune (THAR) Technical Analysis

63 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Tharimmune’s (THAR) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Tharimmune is a Sell.
Tharimmune’s (THAR) 20-Day exponential moving average is 2.94, while Tharimmune’s (THAR) share price is $2.86, making it a Sell.
Tharimmune’s (THAR) 50-Day exponential moving average is 3.21, while Tharimmune’s (THAR) share price is $2.86, making it a Sell.

Tharimmune (THAR) Pivot Points

Sep 20, 2024, 03:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.82
2.88
2.92
2.98
3.02
3.08
3.12
Fibonacci
2.88
2.92
2.94
2.98
3.01
3.04
3.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tharimmune (THAR) Moving Averages

Sep 20, 2024, 03:37 PM
Period
Simple
Exponential
MA5
2.94Sell
2.93Sell
MA10
2.94Sell
2.93Sell
MA20
2.89Sell
2.94Sell
MA50
3.15Sell
3.21Sell
MA100
3.87Sell
5.39Sell
MA200
5.35Sell
14.58Sell
Tharimmune’s (THAR) 10-Day exponential moving average is 2.93, while Tharimmune’s (THAR) share price is $2.86, making it a Sell.
Tharimmune’s (THAR) 100-Day exponential moving average is 5.39, while Tharimmune’s (THAR) share price is $2.86, making it a Sell.
Tharimmune’s (THAR) stock price is $2.86 and Tharimmune’s (THAR) 50-day simple moving average is 3.15, creating a Sell signal.
Tharimmune’s (THAR) stock price is $2.86 and Tharimmune’s (THAR) 100-day simple moving average is 3.87, creating a Sell signal.
Tharimmune’s (THAR) stock price is $2.86 and Tharimmune’s (THAR) 200-day simple moving average is 5.35, creating a Sell signal.

Tharimmune (THAR) Technical Indicators

Sep 20, 2024, 03:37 PM
Name
Value
Implied Action
RSI (14)
44.67
Neutral
STOCH (9,6)
69.36
Neutral
STOCHRSI (14)
61.54
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
11.09
Buy
Williams %R
-53.85
Buy
CCI (14)
-17.32
Neutral
ATR (14)
0.22
-
Ultimate Oscillator
56.10
Neutral
ROC
0.70
Buy
Tharimmune’s (THAR) Relative Strength Index (RSI) is 44.67, creating a Neutral signal.
Tharimmune’s (THAR) Trend Strength Indicator (ADX) is 11.09, creating a Buy signal.
Tharimmune’s (THAR) Commodity Channel Index (CCI) is -17.32, creating a Neutral signal.
Tharimmune’s (THAR) Price Rate of Change (ROC) is 0.70, creating a Buy signal.

FAQ

Is THAR a Buy, Hold, or Sell?
Based on THAR’s technical indicators, THAR is a Strong Sell.
    What is THAR’s RSI (14)?
    THAR’s RSI (14) is 44.67, which suggests THAR is a Neutral.
      What is THAR’s MACD?
      THAR’s MACD is -0.04, which suggests THAR is a Sell.
        What is THAR’s 5-day moving average?
        THAR’s 5-day moving average is 2.94, which suggests THAR is a Sell.
          What is THAR’s 20-day moving average?
          THAR 20-day moving average is 2.89, which suggests THAR is a Sell.
            What is THAR’s 50-day moving average?
            THAR’s 50-day moving average is 3.15, which suggests THAR is a Sell.
              What is THAR’s 200-day moving average?
              THAR’s 200-day moving average is 5.35, which suggests THAR is a Sell.
                What is THAR’s Williams % R (14)?
                THAR’s Williams % R (14) is -53.85, which suggests THAR is a Buy.
                  What is THAR’s CCI (14)?
                  THAR’s CCI (14) is -17.32, which suggests THAR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis